Asia-Pacific Epirubicin Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Dosage (10mg/Vial, 50mg/Vial, 100mg/Vial, and 200mg/Vial), Application (Breast Cancer, Liver Cancer, Bladder Cancer, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
The APAC epirubicin market is expected to grow from US$ 29,679.40 thousand in 2022 to US$ 37,447.28 thousand by 2028; it is estimated to grow at a CAGR of 4.0% from 2022 to 2028.
Rising Prevalence of Cancer Boosts Epirubicin Market
Epirubicin is an anthracycline drug that is used to treat breast cancer, stomach cancers, etc. It reduces the risk of relapse by attacking any remaining tumor cells after surgery or radiation therapy. Further, the number of people diagnosed with liver cancer has been rising, and it is common in several parts of the region. Hence, the rising prevalence of cancer cases is driving the epirubicin market across the region.
Market Overview
The APAC epirubicin market is segmented into China, Japan, India, Australia, South Korea, and the Rest of APAC. The developing economies such as China, India, and Indonesia are investing substantially in infrastructure and industrial development. In APAC, China is the largest market for epirubicin. The market growth is primarily attributed to the growing pharmaceutical industry, increasing developments by the market players, and favorable regulatory policies. Further, the excessive population in China and the rising prevalence of cancer are majorly boosting the demand for cancer drugs. Also, the growing prevalence of cancer in China is likely to increase the demand for cancer treatment. As per the WHO report, in 2020, there were ~4,568,754 new cases of cancer and 3,002,899 cancer-associated deaths in China. Thus, the huge cancer patient population and product and treatment developments by the market players are expected to propel the demand for cancer vaccines in the country.
APAC Epirubicin Market Revenue and Forecast to 2028 (US$ Thousand)
APAC Epirubicin Market Segmentation
The APAC epirubicin market is segmented based on dosage, application, distribution channel, and country
- Based on dosage, the APAC epirubicin market is segmented into 10mg/vial, 50mg/vial, 100mg/vial, and 200mg/vial. The 50mg/vial segment held the largest market share in 2022.
- Based on application, the APAC epirubicin market is segmented into breast cancer, liver cancer, bladder cancer, and others. The breast cancer segment held the largest market share in 2022.
- Based on distribution channel, the APAC epirubicin market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment held the largest market share in 2022.
- Based on country, the APAC epirubicin market is categorized into China, India, Japan, South Korea, Australia, and the Rest of APAC. Further, China dominated the market in 2022.
Fresenius Kabi AG, Hikma Pharmaceuticals PLC, Miracalus Pharma Pvt. Ltd., Mylan N.V., Pfizer Inc., Salius Pharma Pvt Ltd, and Teva Pharmaceutical Industries Ltd. are the leading companies operating in the APAC epirubicin market.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 APAC Epirubicin Market – By Dosage
1.3.2 APAC Epirubicin Market – By Application
1.3.3 APAC Epirubicin Market – By Distribution Channel
1.3.4 APAC Epirubicin Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. APAC Epirubicin Market – Market Landscape
4.1 Overview
4.2 APAC PEST Analysis
4.3 Experts Opinion
5. APAC Epirubicin Market– Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Cancer
5.1.2 Increasing Awareness Regarding Cancer
5.2 Market Restraints
5.2.1 Elevated Risk of Adverse Effects due to Epirubicin
5.3 Future Trends
5.3.1 Increase in Number of Cancer Research Programs
5.4 Impact Analysis
6. Epirubicin Market– APAC Analysis
6.1 APAC Epirubicin Market Revenue Forecasts and Analysis
7. APAC Epirubicin Market Analysis – By Dosage
7.1 Overview
7.2 APAC Epirubicin Market, by Dosage, 2022 & 2028 (%)
7.3mg/Vial
7.3.1 Overview
7.3.2mg/Vial Market Revenue and Forecast to 2028 (US$ Thousand)
7.4mg/Vial
7.4.1 Overview
7.4.2mg/Vial Market Revenue and Forecast to 2028 (US$ Thousand)
7.5mg/Vial
7.5.1 Overview
7.5.2mg/Vial Market Revenue and Forecast to 2028 (US$ Thousand)
7.6mg/Vial
7.6.1 Overview
7.6.2 Mg/Vial Market Revenue and Forecast to 2028 (US$ Thousand)
8. APAC Epirubicin Market Analysis – By Application
8.1 Overview
8.2 APAC Epirubicin Market, by Application, 2022 & 2028 (%)
8.3 Breast Cancer
8.3.1 Overview
8.3.2 Breast Cancer Market Revenue and Forecast to 2028 (US$ Thousand)
8.4 Liver Cancer
8.4.1 Overview
8.4.2 Liver Cancer Market Revenue and Forecast to 2028 (US$ Thousand)
8.5 Bladder Cancer
8.5.1 Overview
8.5.2 Bladder Cancer Market Revenue and Forecast to 2028 (US$ Thousand)
8.6 Others
8.6.1 Overview
8.6.2 Others Cancer Market Revenue and Forecast to 2028 (US$ Thousand)
9. APAC Epirubicin Market Analysis – By Distribution Channel
9.1 Overview
9.2 APAC Epirubicin Market, by Distribution Channel, 2022 & 2028 (%)
9.3 Hospital Pharmacies
9.3.1 Overview
9.3.2 Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Thousand)
9.4 Retail Pharmacies
9.4.1 Overview
9.4.2 Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Thousand)
9.5 Online Pharmacies
9.5.1 Overview
9.5.2 Online Pharmacies Market Revenue and Forecast to 2028 (US$ Thousand)
10. APAC Epirubicin Market – Country Analysis
10.1 Overview
10.1.1 APAC: Epirubicin Market, by Country, 2022 & 2028 (%)
10.1.1.1 China Epirubicin Market Revenue and Forecasts to 2028 (US$ Thousand)
10.1.1.1.1 Overview
10.1.1.1.2 China: Epirubicin Market – Revenue and Forecast to 2028 (US$ Thousand)
10.1.1.1.3 China: Epirubicin Market, by Dosage, 2019–2028 (US$ Thousand)
10.1.1.1.4 China: Epirubicin Market, by Application, 2019–2028 (US$ Thousand)
10.1.1.1.5 China: Epirubicin Market, by Distribution Channel, 2019–2028 (US$ Thousand)
10.1.1.2 Japan Epirubicin Market Revenue and Forecasts to 2028 (US$ Thousand)
10.1.1.2.1 Overview
10.1.1.2.2 Japan: Epirubicin Market – Revenue and Forecast to 2028 (US$ Thousand)
10.1.1.2.3 Japan: Epirubicin Market, by Dosage, 2019–2028 (US$ Thousand)
10.1.1.2.4 Japan: Epirubicin Market, by Application, 2019–2028 (US$ Thousand)
10.1.1.2.5 Japan: Epirubicin Market, by Distribution Channel, 2019–2028 (US$ Thousand)
10.1.1.3 India Epirubicin Market Revenue and Forecasts to 2028 (US$ Thousand)
10.1.1.3.1 Overview
10.1.1.3.2 India: Epirubicin Market – Revenue and Forecast to 2028 (US$ Thousand)
10.1.1.3.3 India: Epirubicin Market, by Dosage, 2019–2028 (US$ Thousand)
10.1.1.3.4 India: Epirubicin Market, by Application, 2019–2028 (US$ Thousand)
10.1.1.3.5 India: Epirubicin Market, by Distribution Channel, 2019–2028 (US$ Thousand)
10.1.1.4 South Korea Epirubicin Market Revenue and Forecasts to 2028 (US$ Thousand)
10.1.1.4.1 Overview
10.1.1.4.2 South Korea: Epirubicin Market – Revenue and Forecast to 2028 (US$ Thousand)
10.1.1.4.3 South Korea: Epirubicin Market, by Dosage, 2019–2028 (US$ Thousand)
10.1.1.4.4 South Korea: Epirubicin Market, by Application, 2019–2028 (US$ Thousand)
10.1.1.4.5 South Korea: Epirubicin Market, by Distribution Channel, 2019–2028 (US$ Thousand)
10.1.1.5 Australia Epirubicin Market Revenue and Forecasts to 2028 (US$ Thousand)
10.1.1.5.1 Overview
10.1.1.5.2 Australia: Epirubicin Market – Revenue and Forecast to 2028 (US$ Thousand)
10.1.1.5.3 Australia: Epirubicin Market, by Dosage, 2019–2028 (US$ Thousand)
10.1.1.5.4 Australia: Epirubicin Market, by Application, 2019–2028 (US$ Thousand)
10.1.1.5.5 Australia: Epirubicin Market, by Distribution Channel, 2019–2028 (US$ Thousand)
10.1.1.6 Rest of APAC Epirubicin Market Revenue and Forecasts to 2028 (US$ Thousand)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of APAC: Epirubicin Market – Revenue and Forecast to 2028 (US$ Thousand)
10.1.1.6.3 Rest of APAC: Epirubicin Market, by Dosage, 2019–2028 (US$ Thousand)
10.1.1.6.4 Rest of APAC: Epirubicin Market, by Application, 2019–2028 (US$ Thousand)
10.1.1.6.5 Rest of APAC: Epirubicin Market, by Distribution Channel, 2019–2028 (US$ Thousand)
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies
11.2.1 Overview
12. Company Profiles
12.1 Pfizer Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Teva Pharmaceutical Industries Ltd.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Salius Pharma Pvt Ltd
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Mylan N.V.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Hikma Pharmaceuticals PLC
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Fresenius Kabi AG
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Miracalus Pharma Pvt. Ltd.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. APAC Epirubicin Market – Revenue and Forecast to 2028 (US$ Thousand)
Table 2. China Epirubicin Market, by Dosage – Revenue and Forecast to 2028 (US$ Thousand)
Table 3. China Epirubicin Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 4. China Epirubicin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Thousand)
Table 5. Japan Epirubicin Market, by Dosage – Revenue and Forecast to 2028 (US$ Thousand)
Table 6. Japan Epirubicin Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 7. Japan Epirubicin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Thousand)
Table 8. India Epirubicin Market, by Dosage – Revenue and Forecast to 2028 (US$ Thousand)
Table 9. India Epirubicin Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 10. India Epirubicin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Thousand)
Table 11. South Korea Epirubicin Market, by Dosage – Revenue and Forecast to 2028 (US$ Thousand)
Table 12. South Korea Epirubicin Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 13. South Korea Epirubicin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Thousand)
Table 14. Incidence, Mortality and Prevalence by cancer site, Australia, 2018
Table 15. Australia Epirubicin Market, by Dosage – Revenue and Forecast to 2028 (US$ Thousand)
Table 16. Australia Epirubicin Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 17. Australia Epirubicin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Thousand)
Table 18. Rest of APAC Epirubicin Market, by Dosage – Revenue and Forecast to 2028 (US$ Thousand)
Table 19. Rest of APAC Epirubicin Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 20. Rest of APAC Epirubicin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Thousand)
Table 21. Recent Growth Strategies
Table 22. Glossary of Terms
LIST OF FIGURES
Figure 1. APAC Epirubicin Market Segmentation
Figure 2. APAC Epirubicin Market, By Country
Figure 3. APAC Epirubicin Market Overview
Figure 4. APAC Epirubicin Market, By Dosage
Figure 5. APAC Epirubicin Market, By Country
Figure 6. APAC: PEST Analysis
Figure 7. Experts Opinion
Figure 8. Impact Analysis of Drivers and Restraints on APAC Epirubicin Market
Figure 9. APAC Epirubicin Market – Revenue Forecasts and Analysis
Figure 10. APAC Epirubicin Market, by Dosage, 2022 & 2028 (%)
Figure 11. APAC 10mg/Vial Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 12. APAC 50mg/Vial Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 13. APAC 100mg/Vial Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 14. APAC 200 Mg/Vial Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 15. APAC Epirubicin Market, by Application, 2022 & 2028 (%)
Figure 16. APAC Breast Cancer Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 17. APAC Liver Cancer Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 18. APAC Bladder Cancer Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 19. APAC Others Cancer Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 20. APAC Epirubicin Market, by Distribution Channel, 2022 & 2028 (%)
Figure 21. APAC Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 22. APAC Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 23. APAC Online Pharmacies Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 24. APAC: Epirubicin Market, by Key Country – Revenue (2022) (US$ Thousand)
Figure 25. APAC: Epirubicin Market, by Country, 2022 & 2028 (%)
Figure 26. China: Epirubicin Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 27. Japan: Epirubicin Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 28. India: Epirubicin Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 29. South Korea: Epirubicin Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 30. Australia: Epirubicin Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 31. Rest of APAC: Epirubicin Market – Revenue and Forecast to 2028 (US$ Thousand)
- Fresenius Kabi AG
- Hikma Pharmaceuticals PLC
- Miracalus Pharma Pvt. Ltd.
- Mylan N.V.
- Pfizer Inc.
- Salius Pharma Pvt Ltd
- Teva Pharmaceutical Industries Ltd.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the APAC epirubicin market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the APAC epirubicin market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the epirubicin market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution